Five-Year Business Highlights
Principal Financial Data
Fiscal year
(millions of yen) |
2020/3
（JGAAP） |
2021/3
（JGAAP） |
2022/3
（JGAAP） |
2023/3
（IFRS） |
2024/3
（IFRS） |
2025/3 (forecast) |
| Net sales / Sales revenue |
116,637 |
121,885 |
137,547 |
144,175 |
148,255 |
150,000 |
| Pharmaceuticals |
101,643 |
106,478 |
120,650 |
121,988 |
125,105 |
128,500 |
| Functional food |
14,994 |
15,406 |
16,897 |
22,187 |
23,150 |
21,500 |
| Operating income |
21,668 |
26,134 |
28,299 |
30,049 |
33,295 |
31,000 |
| Ordinary income |
22,442 |
26,760 |
29,773 |
- |
- |
- |
| Net income attributable to owners of the parent / Profit attributable to owners of the parent |
16,866 |
20,702 |
23,044 |
22,812 |
25,851 |
24,500 |
|
|
|
|
|
|
|
| Depreciation and amortization |
3,468 |
3,550 |
2,933 |
5,041 |
5,023 |
5,800 |
| Capital investment |
2,500 |
2,583 |
4,264 |
7,982 |
6,921 |
5,500 |
| R&D expenses |
13,994 |
16,104 |
26,386 |
24,135 |
31,676 |
31,500 |
|
|
|
|
|
|
|
| Total assets |
175,017 |
197,028 |
210,052 |
237,451 |
263,404 |
| Net assets/Total equity |
145,760 |
162,543 |
176,767 |
195,933 |
220,534 |
| Liabilities |
29,257 |
34,485 |
33,285 |
41,518 |
42,870 |
Net income attributable to owners of the parent
Principal Financial Indicators
| Fiscal year (yen) |
2020/3
（JGAAP） |
2021/3
（JGAAP） |
2022/3
（JGAAP） |
2023/3
（IFRS） |
2024/3
（IFRS） |
|
| Earnings per share (EPS) |
250.42 |
307.37 |
342.14 |
338.7 |
383.82 |
|
| Dividend per share |
86 |
99 |
110 |
114 |
124 |
|
|
|
|
|
|
|
|
| Equity ratio |
83.1 |
82.4 |
84.0 |
82.4 |
83.6 |
| Return on equity (ROE) |
12.0 |
13.5 |
13.6 |
12.1 |
12.4 |
| Payout ratio |
34.3 |
32.2 |
32.2 |
33.7 |
32.3 |
EPS / ROE
- Earnings per share (EPS)
- Return on equity (ROE)
Dividend per share / Payout ratio
Cash Flows
| Fiscal year (millions of yen) |
2020/3
（JGAAP） |
2021/3
（JGAAP） |
2022/3
（JGAAP） |
2023/3
（IFRS） |
2024/3
（IFRS） |
|
| Cash flow from operating activities |
12,737 |
21,388 |
16,018 |
26,170 |
16,289 |
|
| Cash flow from investing activities |
△2,339 |
△1,564 |
△6,359 |
△17,631 |
△9,921 |
|
| Cash flow from financing activities |
△5,660 |
△6,199 |
△6,801 |
△9,605 |
△9,719 |
|
Eleven-Year Financial Data
Eleven-Year financial data from here.
